Advanced Accelerator Applications Announces Two Phase II Studies Evaluating 99MrhAnnexin V-128 Imaging in Cardiovascular and Cardio-Oncology Indications at University of Ottawa Heart Institute and Ottawa Hospital
September 06, 2016 07:00 ET
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear...
Advanced Accelerator Applications Announces FDA Approval of NETSPOT™ (Somakit-TATE), a Kit for the Preparation of Gallium Ga 68 Dotatate for Neuroendocrine Tumor Detection
June 02, 2016 07:00 ET
|
Advanced Accelerator Applications
SAINT-GENIS-POUILLY, France, June 02, 2016 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or “the Company”), an international specialist in molecular nuclear...
Zevacor to Produce SomaKit-TATE Doses for AAA
January 26, 2016 07:00 ET
|
Advanced Accelerator Applications
DULLES, Va., Jan. 26, 2016 (GLOBE NEWSWIRE) -- Zevacor Pharma, Inc. (fka IBA Molecular North America, Inc.), a leader in the manufacture and distribution of radiopharmaceuticals, announced that it...
Combustible Gas Leak Detector
August 26, 2015 15:21 ET
|
Tracer Products
WESTBURY, NY--(Marketwired - August 26, 2015) - Tracer Products manufactures state-of-the-art tools and equipment to make leak detection and repair easy and efficient. The Tracerline® TP-9363...
MELA Sciences Predictive Probability Study Supports Increased Diagnostic Accuracy by Dermatologists for Melanoma
May 08, 2014 08:37 ET
|
MELA Sciences, Inc.
IRVINGTON, NY--(Marketwired - May 8, 2014) - MELA Sciences, Inc. (NASDAQ: MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
Melanoma Diagnostic Developer, MELA Sciences, Hosts Q1 Conference Call Tuesday, May 13th at 4:30 pm ET
May 07, 2014 17:23 ET
|
MELA Sciences, Inc.
IRVINGTON, NY--(Marketwired - May 7, 2014) - MELA Sciences, Inc. (NASDAQ: MELA), developer of the MelaFind® system, an optical diagnostic device approved for use in the U.S. and the European...
Global Next Generation Cancer Diagnostic Devices Market Report: 2013 Edition
November 19, 2013 09:59 ET
|
Research and Markets
Dublin, Nov. 19, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/dn5vq5/global_next)
has announced the addition of the "Global
Next Generation Cancer...
Global Electro-Diagnostic Equipment Market to 2017
November 14, 2013 07:39 ET
|
Research and Markets
Dublin, Nov. 14, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/wwcjgb/global)
has announced the addition of the "Global
Electro-Diagnostic Equipment Market...
INFORM GENOMICS and TESARO Enter Into Collaboration Agreement
October 15, 2013 07:00 ET
|
Inform Genomics
Boston, MA, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based, personalized medicine products for
cancer supportive...
Coagulation Diagnostic Testing Markets 2013
October 01, 2013 09:40 ET
|
Research and Markets
Dublin, Oct. 1, 2013 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/mn99vc/coagulation)
has announced the addition of the "Coagulation
Diagnostic Testing Markets"...